Brief treatment strategies for major depressive disorder: Advice for the primary care clinician

Topics in Advanced Practice Nursing

Volumn 4, Issue 1, 2004, Pages

  Valdivia, Ivan ^a,b   Rossy, Nadine ^a,c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

CLINICAL TRIAL; COGNITION; CONSTIPATION; COPING BEHAVIOR; DROWSINESS; DRUG COST; ELECTROCONVULSIVE THERAPY; EVIDENCE BASED MEDICINE; HEADACHE; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HUMAN; INCREASED APPETITE; MAJOR DEPRESSION; MONITORING; MOOD DISORDER; NAUSEA; ORTHOSTATIC HYPOTENSION; PATIENT; PROFESSIONAL PRACTICE; PSYCHOTHERAPY; REVIEW; RISK FACTOR; SEDATION; SEXUAL DYSFUNCTION; URINARY DYSFUNCTION; VISUAL IMPAIRMENT; WEIGHT GAIN; XEROSTOMIA;

EID: 4043059891     PISSN: 15352250     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Sartorius N, Uestuen TB, Lecrubier Y, Wittchen HU. Depression comorbid with anxiety: results from the WHO study on "Psychological disorders in primary health care." Br J Psychiatry. 1996;168(suppl 30):38-43.
2. Druss BG, Rosenheck MD, Sledge WH. Health and disability costs of depressive illness in a major U. S. corporation. Am J Psychiatry. 2000;157:1274-1278. Abstract
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
4. Pincus HA, Zarin DZ, Tanielian TL, et al. Psychiatric patients and treatments in 1997: findings from the American Psychiatric Practice Research Network. Arch Gen Psychiatry. 1997;56:442-449.
5. Mueller TI, Leon AC, Keller MB, et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry. 1999;156:1000-1006. Abstract
6. Endler NS, Macrodimitris SD, Kocovski NL. Depression: the complexity of self-report measures. J Appl Biobehav Res.1999;5:26-46.
7. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition With Psychotic Screen (SCID-I/P W/ PSY SCREEN). New York: Biometrics Research, New York State Psychiatric Institute; 2001.
8. Lecrubier Y, Sheehan D, Weiller E, et al. The MINI International Neuropsychiatric Interview (MINI): a short diagnostic structured interview. Eur Psychiatry. 1997;12:224-231.
9. Kaufman J, Birmaher B, Brent D. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36:980-988. Abstract
10. Escobar JI, Gomez J, Tuason VB. Depressive phenomenology in North and South American patients. Am J Psychiatry. 1983;140:47-51. Abstract
11. Beck AT, Steer RA, Ball R, Ranieri WF. Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J Personal Assess. 1996;67:588-597.
12. Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63-70. Abstract
13. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Measure. 1977;1:385-401.
14. Quitkin FM, Rabkin JG, Markowitz JM, Stewart JW, McGrath PJ, Harrison W. Use of pattern analysis to identify true drug response. Arch Gen Psychiatry. 1987;44:259-264. Abstract
15. Agency for Healthcare Policy Research: Evidence Report on Treatment of Depression - Newer Pharmacotherapies. San Antonio Evidence-Based Practice Center. Washington, DC: AHCPR, Evidence-Based Practice Centers; 2001.
16. Potter WZ, Manji HK, Rudorfer MV. Tricyclics and tetracyclics. In: Schatzberg AF, Nemeroff CB, eds. American Psychiatric Press Textbook of Psychopharmacology, 2nd ed. Washington, DC: American Psychiatric Press; 1998:199-218.
17. Stewart JW, Quitkin FM, Liebowitz MR, McGrath PJ, Harrison WM, Klein DF. Efficacy of desipramine in depressed outpatients: response according to Research Diagnostic Criteria diagnoses and severity of illness. Arch Gen Psychiatry. 1998;40:220-227.
18. Perry PJ. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. J Affect Disord. 1996;39:1-6. Abstract
19. Thase ME, Greenhouse JB, Frank E, et al. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry. 1997;54:1009-1015. Abstract
20. Zisook S, Braff DL, Click MA. Monoamine oxidase inhibitors in the treatment of atypical depression. J Clin Psychopharmacol. 1985;5:131-137. Abstract
21. Thase ME, Mallinger AG, McKnight D, Himmelhoch JM. Treatment of imipramine-resistant recurrent depression, IV: a double-blind crossover study of tranylcypromine for anergic bipolar depression. Am J Psychiatry. 1992;149:195-198. Abstract
22. Anderson IM, Tomenson BM. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. BMJ. 1995;310:1433-1438. Abstract
23. Trindade E, Devidas M, Topfer L, Coloma C. Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. Can Med Assoc J. 1998;159:1245-1252.
24. Pande AC, Birkett M, Fechner-Bates S, Haskett RF, Greden JF. Fluoxetine versus phenelzine in atypical depression. Biol Psychiatry. 1996;40:1017-1020. Abstract
25. Delgado PL, Price LH, Charney DS, Heninger GR. Efficacy of fluvoxamine in treatmentrefractory depression. J Affect Disord. 1988;15:55-60. Abstract
26. Montgomery SA. Reboxetine: additional benefits to depressed patients. J Psychopharmacol. 1997;11(4 suppl):S9-S15.
27. Cunningham LA, Borison RL, Carman JS, et al. A comparison of venlafaxine, trazodone, and placebo in major depression. J Clin Psychopharmacol. 1994;14:99-106. Abstract
28. Weisler RH, Johnston JA, Lineberry CG, Samara B, Branconnier RJ, Billow AA. Comparison of bupropion and trazodone for the treatment of major depression. J Clin Psychopharmacol.1996;14:170-179.
29. Janicak PG, Davis JM, Gibbons RD, Ericksen S, Chang S, Gallagher P. Efficacy of ECT: a metaanalysis. Am J Psychiatry.1985;142:297-302. Abstract
30. Devanand DP, Sackeim HA, Prudic J. Electroconvulsive therapy in the treatment-resistant patient. Psychiatr Clin North Am. 1991;14:905-923. Abstract
31. Stoudemire A, Hill CD, Morris R, Dalton ST. Improvement in depression-related cognitive dysfunction following ECT. J Neuropsychiatry Clin Neurosci. 1995;7:31-34. Abstract
32. Squire LR, Slater PC. Electroconvulsive therapy and complaints of memory dysfunction: a prospective three-year follow-up study. Br J Psychiatry. 1983;142:1-8. Abstract
33. Shapira B, Gorfine M, Lerer B. A prospective study of lithium continuation therapy in depressed patients who have responded to electroconvulsive therapy. Convulsive Ther. 1995;11:80-85.
34. DeRubeis RJ, Gelfand LA, Tang TZ, Simons AD. Medication versus cognitive behavioral therapy for severely depressed outpatients: mega-analysis of four randomized comparisons. Am J Psychiatry. 1999;156:1007-1013. Abstract
35. Antonuccio DO, Thomas M, Danton WG. A cost-effectiveness analysis of cognitive behavior therapy and fluoxetine (Prozac). Behav Ther. 1997;28:187-210.
36. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. New York: Guilford; 1979.
37. Barlow DH, Durand VM. Abnormal Psychology: An Integrative Approach, 1st edition. Pacific Grove, Calif: Brooks/Cole Publishing Company; 1995.
38. Dobson KS. A meta-analysis of the efficacy of cognitive therapy for depression. J Consult Clin Psychology. 1989;57:414-419.
39. Gaffan EA, Tsaousis I, Kemp-Wheeler SM. Researcher allegiance and meta-analysis: the case of cognitive therapy for depression. J Consult Clin Psychology. 1995;63:966-980.
40. Blackburn IM, Moore RG. Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression. Br J Psychiatry. 1997;171:328-334. Abstract
41. Gloaguen V, Cottraux J, Cucherat M, Blackburn IM. A meta-analysis of the effects of cognitive therapy in depressed patients. J Affect Disord. 1998;49:59-72. Abstract
42. Jarrett RB, Rush AJ. Short-term psychotherapy of depressive disorders: current status and future directions. Psychiatry. 1994;57:115-132. Abstract
43. Hollon SD, DeRubeis RJ, Evans MD, et al. Cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry. 1992;49:774-781. Abstract
44. Evans MD, Hollong SD, Garvey MJ, et al. Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry. 1992;49:802-808. Abstract
45. Klerman GL, Weissman MM, Rounsaville BJ, Chevron ES. Interpersonal Psychotherapy of Depression. New York: Basic Books; 1984.
46. Bowlby J. Attachment and Loss: Volume 1. Attachment. New York: Basic Books; 1969.
47. Bowlby J. Attachment and Loss: Volume 3. Loss, Sadness, and Depression. New York: Basic Books; 1980.
48. Sullivan HS. The Interpersonal Theory of Psychiatry. New York: WW Norton; 1953.
49. Shea MT, Pilkonis PA, Beckham E, et al. Personality disorders and treatment outcome in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry. 1990;147:711-718. Abstract
50. Clark DM, Salkovskis PM, Hackmann A, Middleton H, Anastasiades P, Gelder M. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry. 1994;164:759-769. Abstract
51. Elkin I, Shea MT, Watkins JT, et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program: general effectiveness of treatments. Arch Gen Psychiatry.1989;46:971-982. Abstract
52. Hardy GE, Barkham M, Shapiro DA, Reynolds S, Rees A, Stiles WB. Credibility and outcome of cognitive-behavioural and psychodynamic-interpersonal psychotherapy. Br J Clin Psychology. 1995;34:555-569.
53. Buckwalter KC, Gerdner L, Kohout F, et al. A nursing intervention to decrease depression in family caregivers of persons with dementia. Arch Psychiatr Nurs. 1999;13:80-88. Abstract
54. Saur CD, Harpole LH, Steffens DC, et al. Treating depression in primary care: an innovative role for mental health nurses. J Am Psychiatr Nurses Assoc. 2002;8:159-167.
55. Emery G. Overcoming Depression: A Cognitive-Behavioral Protocol for the Treatment of Depression. Oakland, Calif: New Harbinger Publications; 2000.
56. Barkham M, Shapiro DA, Hardy GE, Rees A. Psychotherapy in two-plus-one sessions: outcomes of a randomized controlled trial of cognitive-behavioral and psychodynamic-interpersonal therapy for subsyndromal depression. J Consult Clin Psychol. 1999;67:201-211. Abstract
57. Bloom BL. Planned short-term psychotherapy for depression: recent controlled outcome studies. Brief Treat Crisis Intervention. 2001;1:169-189.
58. Lejuez CW, Hopko DR, LePage JP, Hopko SD, McNeil DW. A brief behavioral activation treatment for depression. Cogn Behav Pract. 2001;8:164-175.
59. MacDowell JJ. The importance of Hernstein's mathematical statement of the law of effect for behavior therapy. Am Psychologist. 1982;37:771-779.
60. Lejuez H, Hopko DR, Hopko SD. A brief behavioral activation treatment for depression: treatment manual. Behav Mod. 2001;25:255-286.
61. Honey KL, Bennett P, Morgan M. A brief psycho-educational group intervention for postnatal depression. Br J Clin Psychol. 2002;41:405-409. Abstract
62. Rush AJ, Thase ME. Psychotherapies for depressive disorders: a review. In: Maj M, Sartorius N, eds. Depressive Disorders. New York: John Wiley & Sons Ltd; 1999:161-206.
63. Burns D. The Feeling Good Handbook (Revised Edition). New York: Avon Books; 1999.
64. Scogin F, Hamblin D, Beutler L. Bibliotherapy for depressed, older adults: a self-help alternative. Gerontologist. 1987;27:383-387. Abstract
65. Wilkinson G. The role of the practice nurse in the management of depression. Int Rev Psychiatry.1992;4:311-315.
66. Basco MR, Rush AJ. Compliance with pharmacotherapy in mood disorders. Psychiatr Ann.1995;25:269-279.